191 related articles for article (PubMed ID: 31650518)
1. Non-physiologic Bioreactor Processing Conditions for Heart Valve Tissue Engineering.
VeDepo MC; Buse EE; Paul A; Converse GL; Hopkins RA
Cardiovasc Eng Technol; 2019 Dec; 10(4):628-637. PubMed ID: 31650518
[TBL] [Abstract][Full Text] [Related]
2. Design and efficacy of a single-use bioreactor for heart valve tissue engineering.
Converse GL; Buse EE; Neill KR; McFall CR; Lewis HN; VeDepo MC; Quinn RW; Hopkins RA
J Biomed Mater Res B Appl Biomater; 2017 Feb; 105(2):249-259. PubMed ID: 26469196
[TBL] [Abstract][Full Text] [Related]
3. Challenges in developing a reseeded, tissue-engineered aortic valve prosthesis.
Hof A; Raschke S; Baier K; Nehrenheim L; Selig JI; Schomaker M; Lichtenberg A; Meyer H; Akhyari P
Eur J Cardiothorac Surg; 2016 Sep; 50(3):446-55. PubMed ID: 27084195
[TBL] [Abstract][Full Text] [Related]
4. Cyclic flexure and laminar flow synergistically accelerate mesenchymal stem cell-mediated engineered tissue formation: Implications for engineered heart valve tissues.
Engelmayr GC; Sales VL; Mayer JE; Sacks MS
Biomaterials; 2006 Dec; 27(36):6083-95. PubMed ID: 16930686
[TBL] [Abstract][Full Text] [Related]
5. The independent role of cyclic flexure in the early in vitro development of an engineered heart valve tissue.
Engelmayr GC; Rabkin E; Sutherland FW; Schoen FJ; Mayer JE; Sacks MS
Biomaterials; 2005 Jan; 26(2):175-87. PubMed ID: 15207464
[TBL] [Abstract][Full Text] [Related]
6. Tissue engineering of cardiac valves: re-seeding of acellular porcine aortic valve matrices with human mesenchymal progenitor cells.
Knight RL; Booth C; Wilcox HE; Fisher J; Ingham E
J Heart Valve Dis; 2005 Nov; 14(6):806-13. PubMed ID: 16359063
[TBL] [Abstract][Full Text] [Related]
7. 6-month aortic valve implantation of an off-the-shelf tissue-engineered valve in sheep.
Syedain Z; Reimer J; Schmidt J; Lahti M; Berry J; Bianco R; Tranquillo RT
Biomaterials; 2015 Dec; 73():175-84. PubMed ID: 26409002
[TBL] [Abstract][Full Text] [Related]
8. Is Transcatheter Aortic Valve Implantation of Living Tissue-Engineered Valves Feasible? An In Vitro Evaluation Utilizing a Decellularized and Reseeded Biohybrid Valve.
Koenig F; Lee JS; Akra B; Hollweck T; Wintermantel E; Hagl C; Thierfelder N
Artif Organs; 2016 Aug; 40(8):727-37. PubMed ID: 27187768
[TBL] [Abstract][Full Text] [Related]
9. Tissue engineering of human heart valve leaflets: a novel bioreactor for a strain-based conditioning approach.
Mol A; Driessen NJ; Rutten MC; Hoerstrup SP; Bouten CV; Baaijens FP
Ann Biomed Eng; 2005 Dec; 33(12):1778-88. PubMed ID: 16389526
[TBL] [Abstract][Full Text] [Related]
10. The in vitro development of autologous fibrin-based tissue-engineered heart valves through optimised dynamic conditioning.
Flanagan TC; Cornelissen C; Koch S; Tschoeke B; Sachweh JS; Schmitz-Rode T; Jockenhoevel S
Biomaterials; 2007 Aug; 28(23):3388-97. PubMed ID: 17467792
[TBL] [Abstract][Full Text] [Related]
11. Preclinical testing of tissue-engineered heart valves re-endothelialized under simulated physiological conditions.
Lichtenberg A; Tudorache I; Cebotari S; Suprunov M; Tudorache G; Goerler H; Park JK; Hilfiker-Kleiner D; Ringes-Lichtenberg S; Karck M; Brandes G; Hilfiker A; Haverich A
Circulation; 2006 Jul; 114(1 Suppl):I559-65. PubMed ID: 16820637
[TBL] [Abstract][Full Text] [Related]
12. Flow-dependent re-endothelialization of tissue-engineered heart valves.
Lichtenberg A; Cebotari S; Tudorache I; Sturz G; Winterhalter M; Hilfiker A; Haverich A
J Heart Valve Dis; 2006 Mar; 15(2):287-93; discussion 293-4. PubMed ID: 16607913
[TBL] [Abstract][Full Text] [Related]
13. Design and hydrodynamic evaluation of a novel pulsatile bioreactor for biologically active heart valves.
Hildebrand DK; Wu ZJ; Mayer JE; Sacks MS
Ann Biomed Eng; 2004 Aug; 32(8):1039-49. PubMed ID: 15446500
[TBL] [Abstract][Full Text] [Related]
14. The role of organ level conditioning on the promotion of engineered heart valve tissue development in-vitro using mesenchymal stem cells.
Ramaswamy S; Gottlieb D; Engelmayr GC; Aikawa E; Schmidt DE; Gaitan-Leon DM; Sales VL; Mayer JE; Sacks MS
Biomaterials; 2010 Feb; 31(6):1114-25. PubMed ID: 19944458
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia induces near-native mechanical properties in engineered heart valve tissue.
Balguid A; Mol A; van Vlimmeren MA; Baaijens FP; Bouten CV
Circulation; 2009 Jan; 119(2):290-7. PubMed ID: 19118259
[TBL] [Abstract][Full Text] [Related]
16. A New Approach Based on a Multiobjective Evolutionary Algorithm for Accurate Control of Flow Rate and Blood Pressure in Cardiac Bioreactors.
Gosselin J; Bégin-Drolet A; Maciel Y; Ruel J
Cardiovasc Eng Technol; 2020 Feb; 11(1):84-95. PubMed ID: 31667784
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Candidate Cell Populations for the Recellularization of Decellularized Heart Valves.
VeDepo M; Buse E; Paul A; Hopkins R; Converse G
Cell Mol Bioeng; 2018 Jun; 11(3):197-209. PubMed ID: 31719886
[TBL] [Abstract][Full Text] [Related]
18. Cardiac Valve Bioreactor for Physiological Conditioning and Hydrodynamic Performance Assessment.
Tefft BJ; Choe JA; Young MD; Hennessy RS; Morse DW; Bouchard JA; Hedberg HJ; Consiglio JF; Dragomir-Daescu D; Simari RD; Lerman A
Cardiovasc Eng Technol; 2019 Mar; 10(1):80-94. PubMed ID: 30311149
[TBL] [Abstract][Full Text] [Related]
19. Living autologous heart valves engineered from human prenatally harvested progenitors.
Schmidt D; Mol A; Breymann C; Achermann J; Odermatt B; Gössi M; Neuenschwander S; Prêtre R; Genoni M; Zund G; Hoerstrup SP
Circulation; 2006 Jul; 114(1 Suppl):I125-31. PubMed ID: 16820561
[TBL] [Abstract][Full Text] [Related]
20. Progress in developing a living human tissue-engineered tri-leaflet heart valve assembled from tissue produced by the self-assembly approach.
Dubé J; Bourget JM; Gauvin R; Lafrance H; Roberge CJ; Auger FA; Germain L
Acta Biomater; 2014 Aug; 10(8):3563-70. PubMed ID: 24813743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
